检索结果 - Ian Chau
- Showing 1 - 20 results of 104
- Go to Next Page
-
1
Treatment in advanced colorectal cancer: what, when and how? 由 Ian Chau, David Cunningham
出版 2009Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 tria... 由 Alicia Okines, Olivia del Puerto, David Cunningham, Ian Chau, Eric Van Cutsem, Leonard B. Saltz, J Cassidy
出版 2009Artigo -
11
-
12
-
13
Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/... 由 Alicia Okines, S. Ashley, David Cunningham, J. Oates, Andrea Turner, Janine Webb, Claire Saffery, Yu Jo Chua, Ian Chau
出版 2010Artigo -
14
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial 由 Thomas Gruenberger, John Bridgewater, Ian Chau, Pilar Alfonso, Michel Rivoire, Satvinder Mudan, S. Lasserre, Matthias Hermann, Daniel Waterkamp, René Adam
出版 2014Artigo -
15
Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience 由 Hendrik‐Tobias Arkenau, Geoff Chong, David Cunningham, David Watkins, Bhawna Sirohi, Ian Chau, Andrew Wotherspoon, A. Norman, Alan Horwich, Estella Matutes
出版 2007Carta -
16
The impact of primary tumour origins in patients with advanced oesophageal, oesophago–gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four... 由 Ian Chau, A. Norman, David Cunningham, J. Oates, Robert D. Hawkins, Timothy Iveson, M. Nicolson, Peter Harper, Michel Seymour, Tamas Hickish
出版 2009Revisão -
17
Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic can... 由 J.C. Bendell, Eileen M. O’Reilly, Mark R. Middleton, Ian Chau, Howard S. Höchster, Anitra Fielding, Wendy Burke, Howard A. Burris
出版 2015Artigo -
18
Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience 由 Khurum Khan, Clare Peckitt, Francesco Sclafani, David Watkins, Sheela Rao, Naureen Starling, Vikram Jain, Sachin Trivedi, Susannah Stanway, David Cunningham, Ian Chau
出版 2015Artigo -
19
MRI-Diagnosed Tumor Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal Cancer 由 Amy Lord, Nigel D’Souza, Annabel Shaw, Zena Rokan, Brendan Moran, Muti Abulafi, Shahnawaz Rasheed, Anuradha Chandramohan, Alison Corr, Ian Chau, Gina Brown
出版 2020Artigo -
20
Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer 由 Ian Chau, Gina Brown, David Cunningham, Diana Tait, Andrew Wotherspoon, A. Norman, Niall C. Tebbutt, Mark Hill, Paul J. Ross, Alison Massey, J. Oates
出版 2006Artigo
相关主题
Medicine
Internal medicine
Cancer
Oncology
Colorectal cancer
Chemotherapy
Gastroenterology
Biology
Surgery
Immunotherapy
Pathology
Gene
Randomized controlled trial
Confidence interval
Clinical trial
Clinical endpoint
Oxaliplatin
Adverse effect
Breast cancer
Cetuximab
Genetics
Biochemistry
Hazard ratio
Ramucirumab
Alternative medicine
Immunology
Capecitabine
KRAS
Phases of clinical research
Placebo